Apoptosis (8)
Breast cancer (6)
apoptosis (5)
Photodynamic therapy (4)
sodium butyrate (4)
prostate cancer (3)
5-Aminolevulinic acid (2)
breast cancer (2)
Canine mammary gland tumor (2)
combination effect (2)
Drug delivery (2)
Eisenia foetida (2)
Laccase (2)
toll-like receptor 4 (2)
ZIF-8 (2)
<italic>Viscum album</italic> (1)
5-aminolaevulinic acid (1)
5-aminolevulinic acid (1)
5-Sulfosalicylic acid (1)
AKT (1)
Anti-cancer (1)
anti-cancer agent (1)
anticancer effect (1)
B activity (1)
bee venom (1)
Biochemical characterization (1)
Boron (1)
Boswellic acid (1)
Breast cancer cells (1)
cabazitaxel (1)
Cabazitaxel (1)
California worm (1)
Cancer (1)
canine mammary gland tumour (1)
Canine mammary tumors (1)
Carcinoma (1)
Carcinosarcoma (1)
Castration resistant metastatic prostate cancer (1)
Cell cycle (1)
Cell viability (1)
cells (1)
coelomic fluid (1)
Coelomic fluid (1)
Colorectal cancer (1)
Combined therapy (1)
Commercial laccase (1)
complete response (1)
Curcumin (1)
cytotoxicity (1)
Drug resistance (1)
Endometrial adenocarcinoma (1)
Enzyme (1)
ephitelial cell (1)
Exosomes (1)
Feline mammary gland tumor (1)
feline squamous cell carcinoma (1)
Gallic acid (1)
Gemcitabine (1)
Guanidine (1)
hepatitis B (1)
hepatitis B vaccine response (1)
histone deacetylase inhibitor (1)
honey bee (1)
HUVEC (1)
Immunodysregulation (1)
iscador (1)
Key Anticancer effect Antiproliferative Cancer therapy Coleomic fluid Eisenia foetida Colon cancer (1)
Light-emitting diodes (LEDs) (1)
Liver metastasis (1)
lymphoma (1)
Meclofenamic acid (MA) (1)
metabolic dysfunction-associated steatotic liver disease (1)
Metastatic castration-resistant prostate cancer (1)
MiR-135b (1)
MiR-99b (1)
miRNA (1)
MiRNA (1)
MMPs (1)
mTOR signaling (1)
NF-κ (1)
oxidative stress (1)
PEPD gene (1)
Peritonitis carcinomatosis (1)
phthalocyanine (1)
PI3K (1)
prolidase deficiency (1)
Prostate cancer (1)
Prostate Cancer (1)
protective effect (1)
Proteomics (1)
quercetin (1)
Receptor tyrosine kinases (1)
rutaecarpine (1)
rutin (1)
Small cell lung carcinoma (SCLC) (1)
Sodium pentaborate pentahydrate (SPP) (1)
Sodium perborate tetrahydrate (SPT) (1)
subtype (1)
Surgical treatment (1)
Synergism (1)
Taxanes (1)
Three-phase partitioning (1)
Thyroid (1)
Thyroid cancer (1)
TIMPs (1)
Topotecan (TPT) (1)
toxicity (1)
triple negative breast cancer (TNBC) (1)
Type-2 Diabetes (1)
water-soluble (1)